EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 161 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,711 | -96.7% | 88 | -95.1% | 0.00% | -100.0% |
| Q1 2023 | $51,407 | +106.4% | 1,812 | +112.7% | 0.01% | +66.7% |
| Q4 2022 | $24,904 | +55.6% | 852 | +41.5% | 0.00% | +50.0% |
| Q3 2022 | $16,000 | +433.3% | 602 | +937.9% | 0.00% | – |
| Q2 2022 | $3,000 | -50.0% | 58 | -54.0% | 0.00% | -100.0% |
| Q1 2022 | $6,000 | +200.0% | 126 | +162.5% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 48 | +9.1% | 0.00% | – |
| Q3 2021 | $2,000 | +100.0% | 44 | +144.4% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 18 | -50.0% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 36 | +80.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 20 | +25.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 16 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 16 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 16 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |